Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Roberto Freilone"'
Autor:
Irene Dogliotti, Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Silvio Mercadante, Simone Ragaini, Barbara Botto, Mario Levis, Mattia Novo, Marco Ghislieri, Luca Molinaro, Umberto Mortara, Chiara Consoli, Alessio Lonardo, Giulia Bondielli, Simone Ferrero, Roberto Freilone, Umberto Ricardi, Benedetto Bruno, Federica Cavallo
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Relapse and refractory (R/R) rates after first‐line R‐CHOP in diffuse large B cell lymphomas (DLBCL) are ~40% and ~15% respectively. Aims We conducted a retrospective real‐world analysis aimed at evaluating clinical outcomes
Externí odkaz:
https://doaj.org/article/1d7d6e20f9ba4f66901f58389b759e04
Autor:
Corrado Benevolo Savelli, Matteo Bisio, Luca Legato, Filippo Fasano, Elisa Santambrogio, Maura Nicolosi, Deborah Morra, Carola Boccomini, Roberto Freilone, Barbara Botto, Mattia Novo
Publikováno v:
Cancers, Vol 16, Iss 10, p 1830 (2024)
Classical Hodgkin Lymphoma (cHL) is a highly curable disease, but around 20% of patients experience progression or relapse after standard frontline chemotherapy regimens. Salvage regimens followed by autologous stem cell transplants represent the his
Externí odkaz:
https://doaj.org/article/0f5c9be45e9a43859b3c00c1a13ef95c
Autor:
Corrado Benevolo Savelli, Michele Clerico, Barbara Botto, Carolina Secreto, Federica Cavallo, Chiara Dellacasa, Alessandro Busca, Benedetto Bruno, Roberto Freilone, Marco Cerrano, Mattia Novo
Publikováno v:
Cancers, Vol 16, Iss 1, p 46 (2023)
In the last decade, anti-CD19 CAR-T cell therapy has led to a treatment paradigm shift for B-cell non-Hodgkin lymphomas, first with the approval for relapsed/refractory (R/R) large B-cell lymphomas and subsequently for R/R mantle cell and follicular
Externí odkaz:
https://doaj.org/article/493875835995470cb0d007ce2041364e
Autor:
Valentina Giai, Matteo Bisio, Tiziana Rosso, Irene Urbino, Chiara Frairia, Matteo Olivi, Giuseppe Lanzarone, Mattia D’agostino, Eloise Beggiato, Stefano D’ ardia, Ernesta Audisio, Marco Cerrano, Dario Ferrero, Patrizia Pregno, Roberto Freilone
Publikováno v:
HemaSphere, Vol 7, p e6848349 (2023)
Externí odkaz:
https://doaj.org/article/27350578be1845d7b27527d2d16ecfd9
Autor:
Corrado Benevolo Savelli, Mattia Novo, Filippo Fasano, Andrea Evangelista, Federica Cavallo, Carola Boccomini, Lorella Orsucci, Michele Clerico, Veronica Peri, Benedetto Bruno, Barbara Botto, Roberto Freilone
Publikováno v:
HemaSphere, Vol 7, p e9423745 (2023)
Externí odkaz:
https://doaj.org/article/4da7185705a64b03b80033c0ee86eb64
Autor:
Federica Catania, Chiara Frairia, Matteo Olivi, Moreno Festuccia, Davide Rapezzi, Barbara Nicolino, Giulia Arrigo, Eleonora Boscaro, Federica DI Biase, Marco Cerrano, Irene Urbino, Eloise Beggiato, Giuseppe Lanzarone, Chiara Maria Dellacasa, Alessandro Busca, Dario Ferrero, Stefano D’ardia, Ernesta Audisio, Roberto Freilone, Valentina Giai
Publikováno v:
HemaSphere, Vol 7, p e214549f (2023)
Externí odkaz:
https://doaj.org/article/dfea8515cb74466aa5dd64b0b6da2687
Autor:
Paola Maria Manzini, Giovannino Ciccone, Francesco Giuseppe De Rosa, Rossana Cavallo, Valeria Ghisetti, Sergio D’Antico, Claudia Galassi, Fabio Saccona, Anna Castiglione, Nadia Birocco, Tiziana Francisci, Huijing Hu, Clara Pecoraro, Franca Danielle, Luciana Labanca, Anna Maria Bordiga, Marco Lorenzi, Giovanni Camisasca, Osvaldo Giachino, Mauro Pagliarino, Piero Ottone, Ilvana Tiziana Donatella Scuvera, Roberto Guaschino, Roberto Freilone, Pierluigi Berti, Fabrizia Pittaluga, Maria Avolio, Cristina Costa, Samuele Raso, Aurora Nucci, Massimo Milan, Alessandra Baffa, Alessandra Russo, Antonella Tornello, Laura Maddalena, Grazia Delios, Fabio Paolo Marletto, Anna Grazia De Micheli, Alessio Mattei, Stefano Baldassano, Francesca Canta, Maria Luisa Russo, Daniele Bergamo, Francesco Vitale, Marco Maria Liccardi, Alessandra Chinaglia, Andrea Calcagno, Marcella Converso, Chiara Aldieri, Valentina Libanore, Ilaria Blangetti, Valentina Benedetti, Barbara Mitola, Gitana Scozzari, the PLACO COVID Study Group
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background The efficacy of early treatment with convalescent plasma in patients with COVID-19 is debated. Nothing is known about the potential effect of other plasma components other than anti-SARS-CoV-2 antibodies. Methods To determine whet
Externí odkaz:
https://doaj.org/article/e0cc3da5a92e46c6b468d643c3016ec9
Autor:
Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background and objectives: acute myeloid leukemia (AML) patients are at high risk of infections during post induction neutropenia. Recently, the role of antibacterial prophylaxis has been reconsidered due to concerns about the emergence of multi-resi
Externí odkaz:
https://doaj.org/article/d0581b4b379640d0a9a8451bf09c3429
Autor:
Eleonora Boscaro, Irene Urbino, Federica Maria Catania, Giulia Arrigo, Carolina Secreto, Matteo Olivi, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Roberto Freilone, Dario Ferrero, Ernesta Audisio, Marco Cerrano
Publikováno v:
Cancers, Vol 15, Iss 13, p 3512 (2023)
An accurate estimation of AML prognosis is complex since it depends on patient-related factors, AML manifestations at diagnosis, and disease genetics. Furthermore, the depth of response, evaluated using the level of MRD, has been established as a str
Externí odkaz:
https://doaj.org/article/5659076cd4674b19a09737a6ef8e5a55
Autor:
Irene Urbino, Carolina Secreto, Matteo Olivi, Vincenzo Apolito, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Semra Aydin, Roberto Freilone, Chiara Dellacasa, Luisa Giaccone, Dario Ferrero, Ernesta Audisio, Alessandro Busca, Marco Cerrano
Publikováno v:
Cancers, Vol 13, Iss 20, p 5075 (2021)
Acute myeloid leukemia (AML) in older patients is characterized by unfavorable prognosis due to adverse disease features and a high rate of treatment-related complications. Classical therapeutic options range from intensive chemotherapy in fit patien
Externí odkaz:
https://doaj.org/article/213df5665215474790f6b0639f1a6ab8